vs
FIRST US BANCSHARES, INC.（FUSB）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
FIRST US BANCSHARES, INC.的季度营收约是Immunovant, Inc.的1.2倍（$10.4M vs $8.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -899.0%，领先919.4%），Immunovant, Inc.同比增速更快（140.7% vs 7.1%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-59.8M）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
FUSB vs IMVT — 直观对比
营收规模更大
FUSB
是对方的1.2倍
$8.4M
营收增速更快
IMVT
高出133.7%
7.1%
净利率更高
FUSB
高出919.4%
-899.0%
自由现金流更多
FUSB
多$68.9M
$-59.8M
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $8.4M |
| 净利润 | $2.1M | $-75.3M |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | -896.2% |
| 净利率 | 20.4% | -899.0% |
| 营收同比 | 7.1% | 140.7% |
| 净利润同比 | 24.2% | -26.7% |
| 每股收益（稀释后） | $0.36 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBIMVT
| Q4 25 | $10.4M | — | ||
| Q3 25 | $10.5M | — | ||
| Q2 25 | $10.3M | — | ||
| Q1 25 | $9.8M | — | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $10.1M | — | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $9.9M | $8.4M |
净利润FUSBIMVT
| Q4 25 | $2.1M | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $155.0K | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $2.1M | $-75.3M |
营业利润率FUSBIMVT
| Q4 25 | 28.1% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 23.8% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 29.2% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 27.8% | -896.2% |
净利率FUSBIMVT
| Q4 25 | 20.4% | — | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 21.3% | -899.0% |
每股收益（稀释后）FUSBIMVT
| Q4 25 | $0.36 | — | ||
| Q3 25 | $0.32 | — | ||
| Q2 25 | $0.03 | — | ||
| Q1 25 | $0.29 | — | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $0.36 | — | ||
| Q2 24 | $0.34 | — | ||
| Q1 24 | $0.34 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $635.4M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $617.8M |
| 总资产 | $1.2B | $666.4M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBIMVT
| Q4 25 | $73.5M | — | ||
| Q3 25 | $54.7M | — | ||
| Q2 25 | $54.0M | — | ||
| Q1 25 | $56.0M | — | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $82.3M | — | ||
| Q2 24 | $58.2M | — | ||
| Q1 24 | $60.2M | $635.4M |
总债务FUSBIMVT
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBIMVT
| Q4 25 | $105.6M | — | ||
| Q3 25 | $104.2M | — | ||
| Q2 25 | $101.9M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $98.6M | — | ||
| Q3 24 | $98.5M | — | ||
| Q2 24 | $93.8M | — | ||
| Q1 24 | $92.3M | $617.8M |
总资产FUSBIMVT
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | $666.4M |
负债/权益比FUSBIMVT
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-59.8M |
| 自由现金流率自由现金流/营收 | 87.2% | -714.4% |
| 资本支出强度资本支出/营收 | 31.1% | 1.8% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-214.6M |
8季度趋势，按日历期对齐
经营现金流FUSBIMVT
| Q4 25 | $12.3M | — | ||
| Q3 25 | $4.2M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $7.8M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $825.0K | $-59.7M |
自由现金流FUSBIMVT
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $-142.0K | $-59.8M |
自由现金流率FUSBIMVT
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 58.2% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | -1.4% | -714.4% |
资本支出强度FUSBIMVT
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 21.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 9.8% | 1.8% |
现金转化率FUSBIMVT
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
